In Vitro Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis
- PMID: 33753334
- PMCID: PMC8316137
- DOI: 10.1128/AAC.02236-20
In Vitro Susceptibility of Kinetoplastids to Celastroloids from Maytenus chiapensis
Abstract
Leishmaniasis and Chagas are among the most significant neglected tropical diseases. Due to several drawbacks with the current chemotherapy, developing new antikinetoplastid drugs has become an urgent issue. In the present work, a bioassay-guided investigation of the root bark of Maytenus chiapensis on Leishmania amazonensis and Trypanosoma cruzi led to the identification of two D:A-friedo-nor-oleanane triterpenoids (celastroloids), 20β-hydroxy-tingenone (celastroloid 5) and 3-O-methyl-6-oxo-tingenol (celastroloid 8), as promising antikinetoplastid leads. They displayed higher potency on L. amazonensis promastigotes (50% inhibitory concentrations [IC50s], 0.44 and 1.12 μM, respectively), intracellular amastigotes (IC50s, 0.83 and 1.91 μM, respectively), and T. cruzi epimastigote stage (IC50s, 2.61 and 3.41 μM, respectively) than reference drugs miltefosine and benznidazole. This potency was coupled with an excellent selectivity index on murine macrophages. Mechanism of action studies, including mitochondrial membrane potential (Δψm) and ATP-level analysis, revealed that celastroloids could induce apoptotic cell death in L. amazonensis triggered by the mitochondria. In addition, the structure-activity relationship is discussed. These findings strongly underline the potential of celastroloids as lead compounds to develop novel antikinetoplastid drugs.
Keywords: Chagas disease; bioactive natural products; leishmaniasis.
Copyright © 2021 American Society for Microbiology.
Figures



Similar articles
-
Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids.Plants (Basel). 2024 Jan 25;13(3):360. doi: 10.3390/plants13030360. Plants (Basel). 2024. PMID: 38337893 Free PMC article.
-
Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.Eur J Med Chem. 2017 Mar 10;128:25-35. doi: 10.1016/j.ejmech.2017.01.029. Epub 2017 Jan 23. Eur J Med Chem. 2017. PMID: 28152426
-
Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death.Biomed Pharmacother. 2023 Aug;164:114879. doi: 10.1016/j.biopha.2023.114879. Epub 2023 May 19. Biomed Pharmacother. 2023. PMID: 37210899
-
Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.Trop Biomed. 2011 Dec;28(3):471-81. Trop Biomed. 2011. PMID: 22433874 Review.
-
Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.Acta Trop. 2024 Mar;251:107116. doi: 10.1016/j.actatropica.2023.107116. Epub 2023 Dec 28. Acta Trop. 2024. PMID: 38159713 Review.
Cited by
-
Salvadoran Celastraceae Species as a Source of Antikinetoplastid Quinonemethide Triterpenoids.Plants (Basel). 2024 Jan 25;13(3):360. doi: 10.3390/plants13030360. Plants (Basel). 2024. PMID: 38337893 Free PMC article.
-
Global Health Priority Box: Discovering Flucofuron as a Promising Antikinetoplastid Compound.Pharmaceuticals (Basel). 2024 Apr 25;17(5):554. doi: 10.3390/ph17050554. Pharmaceuticals (Basel). 2024. PMID: 38794125 Free PMC article.
-
Mechanism Insight of Cell Death Signaling by Thymol Derivatives on Trypanosomatidae Protozoan Parasites.Antibiotics (Basel). 2025 Apr 5;14(4):383. doi: 10.3390/antibiotics14040383. Antibiotics (Basel). 2025. PMID: 40298509 Free PMC article.
-
Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound.Pharmaceuticals (Basel). 2025 Jul 25;18(8):1106. doi: 10.3390/ph18081106. Pharmaceuticals (Basel). 2025. PMID: 40872498 Free PMC article.
-
Bioprospecting for Anti-Kinetoplastid Drug Discovery from Aloysia citrodora Essential Oil.Int J Mol Sci. 2025 Jun 13;26(12):5697. doi: 10.3390/ijms26125697. Int J Mol Sci. 2025. PMID: 40565163 Free PMC article.
References
-
- Sundar S, Chakravarty J, Meena LP. 2019. Leishmaniasis: treatment, drug resistance and emerging therapies. Expert Opin Orphan D 7:1–10. doi:10.1080/21678707.2019.1552853. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical